Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 20, 2018 21:25 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantCommon Stock | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011343 · doc4.xml · nonDerivative · entry 1 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,132 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:24 UTC |
Arduini Peter JDirector · President & CEO
|
GrantCommon Stock | 26,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011337 · doc4.xml · nonDerivative · entry 3 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,291 F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:24 UTC |
Arduini Peter JDirector · President & CEO
|
GrantCommon Stock | 34,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011337 · doc4.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,377 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:24 UTC |
Arduini Peter JDirector · President & CEO
|
GrantCommon Stock | 25,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011337 · doc4.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,195 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:09 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 262 | $53.41 | $13,993.42 |
DisclosureSEC source: 0001209191-18-007425 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,665 Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:05 UTC |
VINHAIS JOSEPHCorp VP,Global Qlty Assurance
|
GrantCommon Stock | 3,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-000773 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP,Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,035 Read SEC document |
| November 23, 2017 Filed Nov 27, 2017 21:47 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 9 | $48.01 | $432.05 |
DisclosureSEC source: 0001209191-17-062593 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,114 Read SEC document |
| November 23, 2017 Filed Nov 27, 2017 21:47 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 40 | $47.58 | $1,903.20 |
DisclosureSEC source: 0001209191-17-062593 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,123 Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:26 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
SaleCommon Stock | 160 | $47.41 | $7,585.87 |
DisclosureSEC source: 0001209191-17-062051 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,075 Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 00:34 UTC |
GORELICK RICHARD D.Corp VP, Gen Counsel & Sec
|
SaleCommon Stock | 100 | $47.21 | $4,721.00 |
DisclosureSEC source: 0001209191-17-061005 · doc4.xml · nonDerivative · entry 2 GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 00:34 UTC |
GORELICK RICHARD D.Corp VP, Gen Counsel & Sec
|
SaleCommon Stock | 1,400 | $47.19 | $66,066.00 |
DisclosureSEC source: 0001209191-17-061005 · doc4.xml · nonDerivative · entry 1 GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,665 Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 20:23 UTC |
HILL BARBARA BDirector
|
PurchaseCommon Stock | 10,768 | $46.66 | $502,445.65 |
DisclosureSEC source: 0001209191-17-058606 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,540 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of sale prices was $46.53 to $46.67. Read SEC document |
| October 12, 2017 Filed Jan 22, 2018 21:09 UTC |
ESSIG STUARTDirector
|
GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004726 · doc5.xml · nonDerivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414,315 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 22:15 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 9 | $50.14 | $451.26 |
DisclosureSEC source: 0001209191-17-050203 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,163 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 22:15 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 40 | $50.14 | $2,005.60 |
DisclosureSEC source: 0001209191-17-050203 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,172 Read SEC document |
| August 11, 2017 Filed Aug 22, 2017 21:14 UTC |
HOWELL LLOYD JRDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049841 · doc4.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,204 Read SEC document |
| August 04, 2017 Filed Aug 4, 2017 20:11 UTC |
MOREL DONALD E JRDirector
|
PurchaseCommon Stock | 7,500 | $49.23 | $369,225.00 |
DisclosureSEC source: 0001209191-17-047698 · doc4.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,112 Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 20:11 UTC |
MOREL DONALD E JRDirector
|
PurchaseCommon Stock | 2,500 | $49.29 | $123,232.50 |
DisclosureSEC source: 0001209191-17-047698 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,612 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of sale prices was $49.26 to $49.34. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 22:48 UTC |
HILL BARBARA BDirector
|
PurchaseCommon Stock | 5,050 | $49.33 | $249,109.94 |
DisclosureSEC source: 0001209191-17-047209 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,772 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of prices was $49.298 to $49.38. Read SEC document |
| July 17, 2017 Filed Jan 22, 2018 21:09 UTC |
ESSIG STUARTDirector
|
GiftCommon Stock | 24,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-004726 · doc5.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444,315 Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:24 UTC |
ESSIG STUARTDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 135,000 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001209191-17-035819 · doc4.xml · derivative · entry 5 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 135,000 shares Expires 2017-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · derivative.exercise_date: 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:24 UTC |
ESSIG STUARTDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 73,780 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001209191-17-035819 · doc4.xml · derivative · entry 4 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 73,780 shares Expires 2017-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · derivative.exercise_date: 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:24 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 135,000 | $49.90 | $6,736,500.00 |
DisclosureSEC source: 0001209191-17-035819 · doc4.xml · nonDerivative · entry 3 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,077,475 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:24 UTC |
ESSIG STUARTDirector
|
Exercise / conversionCommon Stock | 135,000 | $17.45 | $2,355,750.00 |
DisclosureSEC source: 0001209191-17-035819 · doc4.xml · nonDerivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,212,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:24 UTC |
ESSIG STUARTDirector
|
Exercise / conversionCommon Stock | 73,780 | $17.45 | $1,287,461.00 |
DisclosureSEC source: 0001209191-17-035819 · doc4.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,077,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:25 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 53 | $48.77 | $2,584.81 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,212 Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:25 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 12 | $48.77 | $585.24 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,265 Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 95,429 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · derivative · entry 10 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,780 Underlying: Common Stock · 95,429 shares Expires 2017-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · derivative.exercise_date: 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 68,780 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · derivative · entry 9 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,209 Underlying: Common Stock · 68,780 shares Expires 2017-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · derivative.exercise_date: 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 7 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003,695 Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
GrantCommon Stock | 4,587 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 6 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002,131 Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 95,429 | $48.01 | $4,581,918.46 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 5 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,997,544 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $47.90 to $48.14. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionCommon Stock | 95,429 | $17.45 | $1,665,236.05 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 4 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,092,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionCommon Stock | 68,780 | $17.45 | $1,200,211.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 3 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,997,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:43 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035441 · doc4.xml · nonDerivative · entry 2 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,204 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:43 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035441 · doc4.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,640 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:40 UTC |
SULLIVAN JAMES MDirector
|
GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035436 · doc4.xml · nonDerivative · entry 2 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,604 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:40 UTC |
SULLIVAN JAMES MDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035436 · doc4.xml · nonDerivative · entry 1 SULLIVAN JAMES M · CIK 0001210128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,040 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals on the Forms 4 filed subsequent to that date. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:39 UTC |
Murphy Raymond G.Director
|
GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035434 · doc4.xml · nonDerivative · entry 2 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,241 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:39 UTC |
Murphy Raymond G.Director
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035434 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,677 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:38 UTC |
MOREL DONALD E JRDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035429 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,112 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:37 UTC |
SCHADE CHRISTIAN SDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035423 · doc4.xml · nonDerivative · entry 1 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,668 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:27 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035369 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,722 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:27 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 1,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035369 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,178 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:25 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:25 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,495 Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 44,571 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · derivative · entry 8 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,989 Underlying: Common Stock · 44,571 shares Expires 2017-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · derivative.exercise_date: 25% of the option grant vested on 12/18/2008 (the first anniversary of the grant date of 12/18/2007), and the remaining 75% vested monthly thereafter over 36 months. F6 · balance_after: This stock option was previously reported as covering 208,780 shares of common stock at an exercise price of $34.90 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
SaleCommon Stock | 44,571 | $48.01 | $2,139,844.80 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 2 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,928,764 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $48 to $48.10. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:19 UTC |
ESSIG STUARTDirector
|
Exercise / conversionCommon Stock | 44,571 | $17.45 | $777,763.95 |
DisclosureSEC source: 0001209191-17-034923 · doc4.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,973,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:51 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 13,865 | $45.91 | $636,517.19 |
DisclosureSEC source: 0001209191-17-030370 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,519 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.90 to $45.94. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.